228 related articles for article (PubMed ID: 22044539)
1. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
Selvam P; Bharatwaj B; Porcar L; da Rocha SR
Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
[TBL] [Abstract][Full Text] [Related]
2. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles.
Chokshi U; Selvam P; Porcar L; da Rocha SR
Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
[TBL] [Abstract][Full Text] [Related]
4. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
Wu L; Al-Haydari M; da Rocha SR
Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
[TBL] [Abstract][Full Text] [Related]
5. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry.
Selvam P; Peguin RP; Chokshi U; da Rocha SR
Langmuir; 2006 Oct; 22(21):8675-83. PubMed ID: 17014104
[TBL] [Abstract][Full Text] [Related]
6. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
8. Ethoxylated copolymersurfactants for the HFA134a- interface: interfacial activity, aggregate microstructure and biomolecule uptake.
Selvam P; Chokshi U; Gouch A; Wu L; Porcar L; da Rocha SRP
Soft Matter; 2008 Jan; 4(2):357-366. PubMed ID: 32907250
[TBL] [Abstract][Full Text] [Related]
9. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
Conti DS; Bharatwaj B; Brewer D; da Rocha SR
J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
[TBL] [Abstract][Full Text] [Related]
10. Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure.
Peguin RP; Selvam P; da Rocha SR
Langmuir; 2006 Oct; 22(21):8826-30. PubMed ID: 17014124
[TBL] [Abstract][Full Text] [Related]
11. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
12. HPFP, a model propellant for pMDIs.
Rogueda PG
Drug Dev Ind Pharm; 2003 Jan; 29(1):39-49. PubMed ID: 12602491
[TBL] [Abstract][Full Text] [Related]
13. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
14. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
15. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.
Wu L; Bharatwaj B; Panyam J; da Rocha SR
Pharm Res; 2008 Feb; 25(2):289-301. PubMed ID: 17943419
[TBL] [Abstract][Full Text] [Related]
16. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
17. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants.
Butz N; Porté C; Courrier H; Krafft MP; Vandamme TF
Int J Pharm; 2002 May; 238(1-2):257-69. PubMed ID: 11996829
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation.
Wu L; da Rocha SR
Langmuir; 2007 Nov; 23(24):12104-10. PubMed ID: 17958454
[TBL] [Abstract][Full Text] [Related]
19. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Selvam P; El-Sherbiny IM; Smyth HD
J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
[TBL] [Abstract][Full Text] [Related]
20. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
